Since we're starting to get into the analysis stage of the biotech pipeline, I wanted to discuss a situation that I've seen a number of times, both in my own work and in discussions with others: Team members at the beginning of their career, or who are unhappy with their career progression often get the idea that the best way to get ahead is to become experts in the latest technical fads. Today that means generative models, LLMs, DevOps, crypto, etc. but a few years ago it was a different list. However, startups usually need their employees to spend most of their time on more mundane things like engineering and data munging. So one of two things ends up happening:
I would extend this sentiment beyond a single organization to investing trends in biotech. The recent explosion of fad pre-seed startups in biotech seem very removed from the practical problems that still exist in r&d.
I would extend this sentiment beyond a single organization to investing trends in biotech. The recent explosion of fad pre-seed startups in biotech seem very removed from the practical problems that still exist in r&d.
I agree. I think it's two different manifestations of FOMO - one that involves employees and another that involves founders and investors.